Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus

NCT07720310 is registered in ClinicalTrials.gov with N.N. Alexandrov National Cancer Centre as lead sponsor.

NCT NCT07720310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07720310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus
Lead sponsor
N.N. Alexandrov National Cancer Centre
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 9, 2026
Completion date
June 30, 2030
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

system lupus erythematosus(sle)